Compu­ta­tional Bio & Chem

News

DCVC Leads $14 Million Seed Round for Noetik

By James Hardiman

07 Sep 2023

Deep Tech Opportunities Report

Predictive drug development: toward efficacy from the get-to

01 Sep 2023

News

DCVC leads $12M financing for Kanvas Biosciences to map the human body’s undiscovered territory: the microbiome

By Jason Pontin

22 Jun 2023

News

DCVC leads $13 million seed funding for ShennonBio—revolutionizing immunotherapy through immune cell profiling at unprecedented accuracy, speed

By James Hardiman

13 Mar 2023

DCVC Announcements

DCVC Welcomes 2022

18 Jan 2022

News

Biology-as-a-Platform in the Fight Against Cancer: Freenome Raises $270m Series C

By Zachary Bogue

26 Aug 2021

DCVC Announcements

2021 and Deep Tech: Reasons for Optimism

06 Jan 2021

Thoughts

Using Biology-as-a-Platform to Move from Treatment to Cure

By Zachary Bogue

09 Sep 2020

News

Life sciences and Deep Tech: The next set of solutions to the next set of problems

By Dr. Kiersten Stead, Dr. John Hamer, Matthew Ocko, Zachary Bogue

05 Aug 2020

Thoughts

An Update on How Deep Tech is Arming the Fight Against COVID-19

By Matthew Ocko, Zachary Bogue

07 Jul 2020

Thoughts

Powering a Comprehensive Response to the COVID-19 Crisis Through Deep Tech

By Matthew Ocko, Zachary Bogue

19 Apr 2020

News

Reimagining biologics: AbCellera and Novartis partner to find new disease treatments

By Dr. John Hamer

14 Feb 2019

News

AbCellera Raises $10M Series A: Deep Search for the Immune System

By Matthew Ocko, Zachary Bogue

08 Jan 2019

News

DCVC Bio leads GenEdit’s $8.5 Million Seed Round: Safe, efficient CRISPR and gene therapy delivery platform proven across multiple diseases and cell types

By Matthew Ocko, Zachary Bogue

07 Jan 2019